Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
6.39 Up 0.33(5.45%) Feb 5, 4:00PM EST
Prev Close:6.06
Open:6.07
Bid:5.50 x 100
Ask:9.00 x 1000
1y Target Est:11.25
Beta:0.938812
Earnings Date:Mar 3 - Mar 7 (Est.)
Day's Range:6.04 - 6.43
52wk Range:5.87 - 23.67
Volume:146,238
Avg Vol (3m):303,979
Market Cap:220.15M
P/E (ttm):152.14
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRUp 5.45%220.15M
UCBJYDown 3.61%15.31B
BIIBDown 3.44%57.70B
ABTDown 1.58%55.81B

Key Statistics

Forward P/E (1 yr):49.15
P/S (ttm):2.41
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.08
Quarterly EPS Est (Dec-15) :0.06
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback